GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...
Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system ...
Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief Executive Officer, John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan ...
Z-endoxifen has demonstrated efficacy in phase 1 and 2 trials, improving progression-free survival and tumor response in ...
Furthermore, GLP-1 drugs had a favorable safety profile versus aspirin, particularly with respect to bleeding events, said ...
Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.
“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...
Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released its 2026 Drugs to Watch ...
Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...
Diabetes medications found to influence cancer growth in unexpected ways What if the drugs millions take for diabetes every ...
Celcuity Inc. soared on best-in-class Phase 3 breast cancer data. Click to see why I have a Buy rating on CELC due to data, regulatory filings, and potential M&A.
Long COVID—defined as symptoms persisting ≥ 2 months beyond acute SARS-CoV-2 infection without alternative explanation—now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback